http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022131408-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3fa9d3e06cf00a61c051432f0e1c3c4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
filingDate 2020-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab689c852b41bc9b8117c4f28e70ca5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0e60ca4a7cd51e41881d52c3b0dd549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd2b4b0668f2b1d8fc1dddf467bd861e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a01117ef61c56c3b060edcb290fd4bd8
publicationDate 2022-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022131408-A1
titleOfInvention Method for preparing high-purity antisense oligonucleotide
abstract The present invention relates to a method for preparing a high-purity antisense oligonucleotide. The antisense oligonucleotide intended to be synthesized by the present inventors is a nucleic acid therapeutic agent having a PS backbone as an 18-mer single DNA sequence, wherein a synthesizer AKTA OligoPilot 100 (OP100) is used in the development of a synthesis process, and the antisense oligonucleotide preparation method increases yield and purity by optimizing parameters for each step. The present invention enables the preparation of an antisense oligonucleotide having minimized impurities.
priorityDate 2020-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012184724-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1008649-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150043415-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005267300-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009240332-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID477167784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167117375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9700

Total number of triples: 29.